Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 26;11:9979–9988. doi: 10.2147/CMAR.S199188

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Duan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Plasma ATO concentration. Plasma concentration of ATO was highest at 10-minutes post treatment then decreased over time both in the CSM-ATO and cTACE-ATO groups. Meanwhile, plasma concentration of ATO in CSM-ATO group was decreased at 10=minutes and 20-minutes post treatment compared with the cTACE-ATO group. Comparison between two groups at the same time point was determined by t test. P < 0.05 was considered significant. *P < 0.05.

Abbreviations: ATO, arsenic trioxide; CSM, CalliSpheres Microspheres; cTACE, conventional transcatheter arterial chemoembolization.